OPRX

OptimizeRx Corporation

OptimizeRx Corp is a technology solutions company serving the healthcare industry. It is engaged in providing consumer and physician platforms. Its core product offering is OPTIMIZERx and SampleMD software application.

OptimizeRx Corporation (OPRX) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B); its weakest is Growth (C-). The rating has held at C+ for 7 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.8 / 5.0
C+
Value
B-
Factor Score 2.9 / 5.0
Growth
C-
Factor Score 1.9 / 5.0
Profitability
B
Factor Score 3.4 / 5.0
Momentum
B
Factor Score 3.3 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 36.7
EV / EBITDA 10.5
Rev Growth YoY -29.8%
Gross Margin 73.2%
Price Return 3M -13.4%
Price Return 12M -54.5%
Catalyst Signal 0.00
Market Cap $138.3M
TTM Revenue $98.7M
Price / Sales 1.4
ROE 3.7%

Historical Factor Score Progression

Held C+ for 7 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B- (2.9) C- (1.9) B (3.4) B (3.3) C+ (2.6) C+ (2.8)
2026-11-07 B- (2.9) C- (1.9) B (3.3) B (3.3) C+ (2.7) C+ (2.8)
2026-10-31 B- (2.9) C- (1.9) B (3.3) B (3.2) C+ (2.7) C+ (2.8)
2026-10-24 B- (2.9) C- (1.9) B (3.3) B- (3.1) C+ (2.6) C+ (2.8)
2026-10-17 B- (3.0) C- (1.9) B (3.3) B- (2.9) C+ (2.6) C+ (2.7)
Page 1 of 8
…